Login Get Started
Browse Breadcrumb chevron Shares Breadcrumb chevron Breadcrumb chevron Breadcrumb chevron Redwood Pharma AB
Redwood Pharma AB logo

REDW TO 1 - Redwood Pharma AB News Story

SEK0.008 0.0  0.0%

Last Trade - 29/08/17

Sector
RiskRating
Size
Style
Market Cap £n/a
Enterprise Value £n/a
Revenue £n/a
Position in Universe th / 1829
Quality
Value
Momentum
StockRank™
StockReport™
Tools
Compare with... Run through checklist
Accounts
Balance sheet Income statement Cashflow statement Dividend summary
Charts News Discussions REDW TO 1 Dividends
All News

BRIEF-Redwood Pharma enters into agreement with CRO for clinical phase II trial

Redwood Pharma AB News
Fri 1st September, 2017 7:28am
Sept 1 (Reuters) - REDWOOD PHARMA AB  REDWPH.ST : 
    * ENTERS INTO AGREEMENT WITH CRO FOR CLINICAL PHASE II TRIAL 
 
Source text for Eikon:  ID:nWkr9Rl3s3  
Further company coverage:  REDWPH.ST  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Redwood Pharma AB

See all news
BRIEF-Redwood Pharma Q3 operating loss widens to SEK 5.2 mln
16th Nov '17 News
BRIEF-Redwood Pharma enters into agreement with CRO for clinical phase II trial
1st Sep '17 News
BRIEF-Redwood Pharma Q2 operating loss widens to SEK 5.1 mln
30th Aug '17 News
BRIEF-Redwood Pharma signs agreement regarding GMP production
29th Jun '17 News
BRIEF-Redwood pharma: rights issue subscribed to 74%
27th Jun '17 News
© Stockopedia 2021, Refinitiv, Share Data Services.
Youtube Instagram RSS
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.